The Sing IMT improved distance and near vision at 6 months in patients with late-stage age-related macular degeneration, with minimal impact on the corneal endothelium, according to a study published in Heliyon.
“The Sing IMT brings significant vision back to patients suffering from late-stage AMD, enhancing quality of life through functional independence in tasks like reading and mobility,” study co-author Mario Damiano Toro, PhD, DiSSO, FEBO, of the University Hospital Federico II, Naples, Italy, told Healio. “These patients have lives that are impacted greatly by this